On October 18, 2023, MEI Pharma Inc announced that it has filed a definitive consent revocation statement with Securities and Exchange Commission in connection with the consent solicitation initiated by Anson Advisors and Cable Car Capital to remove the entire Company board of directors, recommended the shareholders disregard any Anson and Cable Car consent solicitation materials they may receive and protect their investment in the Company by signing and returning the Company?s consent revocation card, which they will soon receive by mail.